We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $999B
1-Year Est. Return 46.22%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+8.64%
1 Year Est. Return
+46.22%
3 Year Est. Return
+150.45%
5 Year Est. Return
+185.95%
10 Year Est. Return
+871.56%
AUM
$622B
AUM Growth
+$11.2B
Cap. Flow
-$15.9B
Cap. Flow %
-2.55%
Top 10 Hldgs %
26.59%
Holding
3,066
New
113
Increased
1,569
Reduced
1,081
Closed
107

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$1.6B
2
VZ icon
Verizon
VZ
+$1.3B
3
USB icon
US Bancorp
USB
+$1.26B
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$1.26B
5
LRCX icon
Lam Research
LRCX
+$1.18B

Sector Composition

Rank Sector Weight
1 Technology 26.7%
2 Healthcare 19.64%
3 Financials 12.72%
4 Consumer Discretionary 10.95%
5 Communication Services 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LILA icon
2951
Liberty Latin America Class A
LILA
$1.66B
– –
-56,233
Closed -$237K
LMND icon
2952
Lemonade
LMND
$3.48B
– –
-10,025
Closed -$213K
MCB icon
2953
Metropolitan Bank Holding Corp
MCB
$1.11B
– –
-131,934
Closed -$8.49M
MUX icon
2954
McEwen Inc
MUX
$1.17B
– –
-45,380
Closed -$148K
NGNE icon
2955
Neurogene
NGNE
$567M
– –
-1,015
Closed -$13K
NOTV
2956
DELISTED
Inotiv
NOTV
– –
-14,753
Closed -$249K
NVVE
2957
DELISTED
Nuvve Holding Corp
NVVE
– –
0
– -$52K
IMDX
2958
Insight Molecular Diagnostics
IMDX
$128M
– –
-1,830
Closed -$27K
PBYI icon
2959
Puma Biotechnology
PBYI
$504M
– –
-45,400
Closed -$108K
PSFE icon
2960
Paysafe
PSFE
$336M
– –
-4,366
Closed -$73K
AIXC
2961
AIxCrypto Holdings Inc
AIXC
$36.5M
– –
-258
Closed -$35K
QURE icon
2962
uniQure
QURE
$2.65B
– –
-11,500
Closed -$216K
RENT
2963
Rent the Runway
RENT
$56.7M
– –
-141,882
Closed -$6.24M
RGCO icon
2964
RGC Resources
RGCO
$222M
– –
-11,879
Closed -$251K
RLX icon
2965
RLX Technology
RLX
$2.05B
– –
-13,300
Closed -$14K
HIND
2966
Vyome Holdings
HIND
$14.3M
– –
0
– -$11K
SOAR icon
2967
Volato Group
SOAR
$9.63M
$0 ﹤0.01%
+4,430
New +$1.11M
SPRY icon
2968
ARS Pharmaceuticals
SPRY
$406M
– –
-26,500
Closed -$140K
SRDX
2969
DELISTED
Surmodics
SRDX
– –
-8,419
Closed -$256K
SWBI icon
2970
Smith & Wesson
SWBI
$639M
– –
-10,670
Closed -$111K
TFIN icon
2971
Triumph Financial Inc
TFIN
$1.47B
– –
-3,737
Closed -$204K
UAVS icon
2972
AgEagle Aerial Systems
UAVS
$62.4M
– –
-74
Closed -$35K
VONG icon
2973
Vanguard Russell 1000 Growth ETF
VONG
$47.2B
– –
-220
Closed -$57K
VV icon
2974
Vanguard Morningstar Large-Cap ETF
VV
$54.8B
– –
-280
Closed -$46K
WB icon
2975
Weibo
WB
$1.59B
– –
-3,218,397
Closed -$55M

Similar funds

T. Rowe Price Associates's Q4 2022 Portfolio in Review

As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
  • T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
  • T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
  • T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
  • T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
  • T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
  • T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.

Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.